/stocks — the workspaceLOADING
BOSTON SCIENTIFIC CORP (BSX) is a surgical & medical instruments & apparatus company. Piotroski F-Score 8/8. 16 insider Form 4 filings in the last 90 days. Next earnings projected around 2026-07-22 from BSX's year-over-year reporting pattern (not yet company-confirmed). Fundamentals from SEC filings; prices are end-of-day.
EOD daily bars · delayed, not real-time · data: DatabentoCharting by TradingView Lightweight Charts™
XBRL company facts, SEC EDGAR. TTM = last four reported quarters. Valuation ratios arrive with a price source — we don't fake quotes.
FY ending 2025-12-31 vs 2024-12-31. original 1968 formula; calibrated on manufacturers, read financials/REITs with care
A plain-English read on BSX plus an auto-SWOT — built from BSX's SEC filings and market data, every point cited, nothing invented. Educational, not investment advice.
Four AI analysts — a bull, a bear, a risk manager, and a PM — debate BSX using only the SEC-filing and market facts below. Every point cites its evidence; nothing is invented. This is educational research, not investment advice.
Educational only — not financial advice. Data from SEC EDGAR public filings; no live market data is shown. Figures reflect the company's own reported XBRL facts and may lag.
| Habiger David CDirector | BUY | $251K | view → |
| LUDWIG EDWARD JDirector | BUY | $203K | view → |
| Pegus CherylDirector | BUY | $100K | view → |
| PRIMECAP Management | $2.04B | 1.6% of portfolio |
| Gilbert CisnerosU.S. Representative · CA-39 | BUY | $1,001 - $15,000 | filed 2026-07-02 |
| Gilbert CisnerosU.S. Representative · CA-39 | SELL | $1,001 - $15,000 | filed 2026-07-02 |
| Gilbert CisnerosU.S. Representative · CA-39 | BUY | $1,001 - $15,000 | filed 2026-06-08 |
| Gilbert CisnerosU.S. Representative · CA-39 | BUY | $1,001 - $15,000 | filed 2026-06-08 |
| Gilbert CisnerosU.S. Representative · CA-39 | BUY | $1,001 - $15,000 | filed 2026-06-08 |
Projected from BSX's own SEC 8-K filing history — the year-over-year reporting pattern (~50% land the exact day, ~90% within a week). No analyst estimates, no scraped calendars, nothing invented. It upgrades to a confirmed date + time the moment BSX files its announcement.
BSX has rallied after 5 of its last 8 earnings reports.
Earnings reactions have been moderate.
BSX has traded higher after most recent earnings releases.
The average is inflated by its most volatile prints (+10.4% and -15.3%).
A more typical earnings reaction has been approximately ±4.4%.
Realized close-to-close history only — no options-implied move, no analyst estimates.
| Reported | Close-to-close |
|---|---|
| 2026-04-22 | +10.4% |
| 2026-02-04 | -15.3% |
| 2025-10-22 | +2.5% |
| 2025-07-23 | +3.0% |
| 2025-04-23 | +6.4% |
| 2025-02-05 | +1.4% |
| 2024-10-23 |
Earnings dates are the company's 8-K Item 2.02 filings (SEC). Reactions from Databento EOD.
| -3.3% |
| 2024-07-24 | -5.5% |